The Europe Intravenous Infusion Pump Market would witness market growth of 8.2% CAGR during the forecast period (2021-2027).
Infusion pumps like implantable pumps, ambulatory chemotherapy pumps, and insulin pumps are very helpful in the treatment of various diseases like cancer and diabetes in the home care setup. Ambulatory infusion pumps are very handy or wearable. These infusion pumps help in delivering fluids like medicines, nutrients, and antibiotics in a patient’s body accurately in a controlled surrounding. They are most commonly seen in medical facilities like infusion clinics, hospitals, home settings, ambulatory surgery centers, and long-term care facilities.
However, the demand for home healthcare setup has surged in the last few years due to the high cases and prevalence of chronic diseases and expanding healthcare expenditure, particularly on hospitalization. In addition, home healthcare serves patients with a feasible option in comparison to expensive hospital care, which leads to a reduction in the public expenditure on healthcare services. There is an increasing requirement of decreasing hospital stays, and thus patients are majorly adopting ambulatory infusion pumps, which are inexpensive than other infusion pumps and are also easier to use.
With the favorable policies and high investment of governments in the healthcare sector, the demand for intravenous infusion pumps would augment in the region. Additionally, as the cases of chronic diseases like cancer, cardiovascular diseases, diabetes and many more are increasing, the demand for more advanced systems like infusion pumps would accelerate to provide better treatment to the patients.
Moreover, the supportive insurance and reimbursement policies in various nations of the region are also estimated to propel the growth of the regional intravenous infusion pumps market. People are highly adopting handy or portable infusion pumps to regularly administer their health conditions and the increasing adoption of medical home care setup is also fueling the market growth of this region during the forecast period.
The Germany market dominated the Europe Analgesia/Pain Management Market by Country in 2020, thereby, achieving a market value of $50.4 million by 2027. The UK market is exhibiting a CAGR of 8.9% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 11.3% during (2021 - 2027).
Based on Type, the market is segmented into Volumetric Infusion Pumps, Syringe Infusion Pumps and Patient Controlled Analgesia Infusion Pumps. Based on Application, the market is segmented into Oncology, Parenteral Nutrition, Analgesia/Pain Management and Others. Based on End User, the market is segmented into Hospitals & Clinics, Home Healthcare and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Intravenous Infusion Pump Market Size will Hit USD 8.2 Billion by 2027, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Medtronic PLC, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Smiths Group PLC, Boston Scientific Corporation, and Micrel Medical Devices SA.
By Type
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 